Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

764.85INR
3:54pm IST
Change (% chg)

Rs-5.80 (-0.75%)
Prev Close
Rs770.65
Open
Rs774.00
Day's High
Rs777.40
Day's Low
Rs762.15
Volume
262,629
Avg. Vol
302,621
52-wk High
Rs933.70
52-wk Low
Rs706.40

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is an India-based generic and pharmaceutical company. The Company's business segments include US Business, which includes Western Europe, Canada, Australia, New Zealand and Other Markets; Indian Branded Generics Business, including Global Consumer Healthcare Business, and Emerging Markets,... (more)

Overall

Beta: 0.30
Market Cap(Mil.): Rs1,852,479.00
Shares Outstanding(Mil.): 2,406.75
Dividend: 1.00
Yield (%): 0.13

Financials

  SUN.BO Industry Sector
P/E (TTM): 30.01 37.62 37.34
EPS (TTM): 25.65 -- --
ROI: -- 14.78 14.24
ROE: -- 15.65 15.22

Sun Pharma first-quarter profit boosted by Gleevec generic

MUMBAI Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States.

12 Aug 2016

India's Sun Pharma Q1 profit boosted by Gleevec generic

MUMBAI, Aug 12 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported a quarterly profit that beat analysts' estimates, helped by its exclusive launch of the first generic version of leukaemia drug Gleevec in the United States.

12 Aug 2016

BUZZ-India's Sun Pharma rises on U.S. FDA nod for generic diabetes drug

** Sun Pharmaceutical Industries rises as much as 1.4 pct after the drugmaker gets approval from U.S. health regulators for its generic version of Glumetza tablets, which treat type 2 diabetes

02 Aug 2016

BUZZ-India's Sun Pharma up; Co signs licence deal for Psoriasis treatment

** Shares of Indian drugmaker Sun Pharmaceutical Industries rise as much as 2.36 pct to their highest in nearly two months

28 Jul 2016

Exclusive: Teva, Mylan eye Pfizer's Brazil venture, sources say

SAO PAULO Teva Pharmaceutical Industries Ltd and Mylan NV have shown preliminary interest in a Brazilian generic drugmaking joint-venture in which Pfizer Inc has a 40 percent stake, two people familiar with the process said.

26 Jul 2016

Teva, Mylan eye Pfizer's Brazil venture, sources say

SAO PAULO Teva Pharmaceutical Industries Ltd and Mylan NV have shown preliminary interest in a Brazilian generic drugmaking joint-venture in which Pfizer Inc has a 40 percent stake, two people familiar with the process said.

26 Jul 2016

BUZZ-India's Sun Pharma down; gains in early trade on share buyback

** Shares of Sun Pharmaceutical Industries rise as much as 1.65 pct in early trade, but down 0.5 pct as of 0552 GMT

24 Jun 2016

India's Sun Pharma enters dermatology segment to expand retail offering

MUMBAI, June 8 India's Sun Pharmaceutical Industries Ltd said on Wednesday it had entered the dermatology segment as part of an initiative to further expand its retail offerings.

08 Jun 2016

Morning News Call - India, June 1

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_06012016.pdf FACTORS TO WATCH 10:30 am: Federal cabinet likely to meet in New Delhi. Agenda not given. GMF: ASIA LIVECHAT - MARKETS FOCUS with Michael Every, Head of Financial Markets Research-Asia-Pacific, Rabobank Lots happening in Asia. While China seems to have cooled down a bit, we have the the BOJ piling on suprises nearly every policy meet. Also

01 Jun 2016

Sun Pharma forecasts annual sales below estimates, shares fall

MUMBAI India's Sun Pharmaceutical Industries Ltd issued a weaker-than expected annual sales outlook as it grapples with increased competition in the United States as well as supply constraints, sending its shares 5 percent lower.

31 May 2016

Earnings vs. Estimates